Blockbuster obesity drug Wegovy has been approved in China, opening the door for maker Novo Nordisk to begin selling it in the world’s second-largest economy, where the appetite for similar treatments is surging.
Related Posts
EVs Are Cheaper Than Ever. Can Car Buyers Be Won Over?
Discounts abound as automakers and dealers try to entice hesitant shoppers to make the switch.
7-Eleven Parent Asks Circle K Owner to Improve Takeover Bid
Japan’s Seven & i said it would be open to discussions with the Canadian owner of Circle K stores if the latter improves its $39 […]
Energy & Utilities Roundup: Market Talk
Find insight on nuclear energy, TC Energy, Duke Energy and more in the latest Market Talks covering energy and utilities.